BAXTER

Company Overview

Baxter International Inc. focuses on various crucial healthcare products, offering products and therapies for hospitals, clinics, emergency rooms, operation rooms, pharmacies, and intensive care units. The company provides dialysis therapies, infusion systems, pharmaceuticals (the company has many products, not all, but a few are mentioned in the product portfolio table), and various medical products. Hospitals, nursing homes, dialysis centers, and rehabilitation centers utilize these products and systems. As of December 31, 2023, the company employed nearly 60,000 people, and it manufactured products and solutions in more than 20 countries while marketing it in more than 100 countries.

Baxter International Inc. operates its business through its geographic segments: the Americas, which includes North and South America; Europe, the Middle East, and Africa (EMEA); and the Asia-Pacific region. Each segment offers a broad range of healthcare products. The company offers nutritional products, including ready-to-use premixes of parenteral nutrition with nutritionally balanced formulations.

Baxter is continuously working to improve the healthcare sector. It recently acquired Hill-Rom, a medical technology company engaged in frontline care products, patient support systems, and surgical solutions. This acquisition aims to create a changing healthcare system and to increase global patient care through collaboration among the top MedTech companies.

Financial Highlights (FY 2024)

Company's Business Segments

• Medical Products and Therapies : Infusion Therapies and Technologies, Advanced Surgery
• Healthcare Systems and Technologies : Care and Connectivity Solutions, Front Line Care
• Pharmaceuticals : Injectables and Anesthesia, Drug Compounding
• Other : Other sales primarily represent revenues earned by certain of our Manufacturing facilities from Contract manufacturing activities, Royalty income under a business development arrangement.